Companies: 10,795·Total market cap: $144.5T
Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.

QLGNNASDAQHealthcare
$3.21
+$0.17(+5.59%)
Market Cap$5430810
P/E Ratio—
52W High$8.81
52W Low$1.61
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Qualigen Therapeutics, Inc.（QLGN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · QLGN · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-7.08qlgn eps ttm · qlgn earnings per shareEarnings history
PE Ratio (TTM)—qlgn pe ratio ttm · qlgn price to earningsPE Ratio deep dive
Revenue (TTM)0.00qlgn revenue ttm · qlgn annual revenueFull revenue history
Dividend Yield不分红does qlgn pay dividends · qlgn dividend yieldDividend history
Shares Outstanding2.4Mqlgn shares outstanding · qlgn floatShares outstanding history
Next EarningsTBAqlgn earnings date · qlgn next earningsEarnings history

探索 Qualigen Therapeutics, Inc. 数据

qlgn stock data · financials
市值$5.4Mqlgn market cap · qlgn valuation
分析师预测—
股息不分红does qualigen therapeutics, inc. pay dividends · qlgn dividend yield
营收—qualigen therapeutics, inc. annual revenue · qlgn revenue
盈利EPS $-8.11+53.07%qlgn earnings · qlgn eps
市盈率—qlgn pe ratio · qlgn price to earnings

财务快照

完整财报
FY 2025Revenue$0.00
202320242025
qualigen therapeutics, inc. revenue · qlgn revenue 2025
FY 2025Net Income-$19.5M▼ 217.07% YoY
202320242025
qualigen therapeutics, inc. net income · qlgn profit 2025
FY 2025EPS$-8.11▲ +53.07% YoY
202320242025
qlgn eps · qualigen therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$23.0MEPS: $-7.08View income statement →

股票表现

完整历史
1D+0.00%
1W+28.40%
1M+0.00%
3M+13.03%
YTD-23.57%
1Y-17.69%
5Y-99.81%

关于 Qualigen Therapeutics, Inc.

CEOKevin A. Richardson II
IPO DateJun 23, 2015
Employees4
CountryUS
Websiteqlgntx.com

Qualigen Therapeutics, Inc. a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. Th…

BiotechnologyHealthcareNASDAQUS

what is qualigen therapeutics, inc. · qlgn stock overview · qualigen therapeutics, inc. company profile · who is qualigen therapeutics, inc. ceo · qlgn NASDAQ · qualigen therapeutics, inc. headquarters · qualigen therapeutics, inc. business segments

关于股票概览与关键数据

Qualigen Therapeutics, Inc.（QLGN）是 Biotechnology 行业的 Healthcare 类公司，于 Jun 23, 2015 在 NASDAQ 上市。截至最近交易日，QLGN 股价为 $3.21，市值约为 $5.4M。过去12个月累计回报 -17.69%，年初至今回报 -23.57%。

2025 财年 Qualigen Therapeutics, Inc. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Qualigen Therapeutics, Inc.（QLGN）股价为 $3.21，在 NASDAQ 上市，52周区间为 $1.61 – $8.81。

QLGN 最新股价QLGN quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议